OPTIMIZED EARLY-LATE PROMOTER COMBINED WITH REPEATED VACCINATION FAVORS CYTOTOXIC T CELL RESPONSE AGAINST ANTIGENS IN REPLICATION DEFICIENT RECOMBINANT VIRUS VACCINES

• 收藏
• 分享

专利权人:

Bavarian Nordic A/S

发明人:

Steigerwald, Robin,Brinkmann, Kay,Hausmann, Jürgen,Baur, Karen,Dirmeier, Ulrike

申请号：

AU2017228587

公开号：

AU2017228587B2

申请日:

2017.09.13

申请国别(地区):

AU

年份:

2019

代理人:

摘要：

#$%^&*AU2017228587B220191024.pdf#####ABSTRACT The present invention relates to a replication deficient recombinant virus encoding at least one antigen and/or antigenic epitope, wherein expression of said antigen and/or antigenic epitope is regulated by a transcriptional control element comprising at least two elements driving early expression of said antigen and/or antigenic epitope and the use of said replication deficient recombinant virus as medicament or vaccine.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/